Erectile Dysfunction
📧 Sign up to get email alerts when something new happens for Erectile Dysfunction.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-06-15Clinical Trial Update: Safety and Tolerability of a Novel Implantable Neurostimulator for Ameliorate Erectile Function on Spinal Cord Injured Patients [NA]
A clinical trial update reporting withdrawal of a study evaluating the safety and tolerability of a novel implantable neurostimulator intend…
-
CLINICAL_TRIALS withdrawal · 2025-04-24Clinical Trial Update: Adipose-derived SVF for Treatment of Erectile Dysfunction (ED) [NA]
A clinical trial evaluating adipose-derived stromal vascular fraction (SVF) for erectile dysfunction has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-04-11Clinical Trial Update: LiSWT for Men With Erectile Dysfunction [NA]
A clinical trial evaluating low-intensity shockwave therapy for erectile dysfunction has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-09-19Clinical Trial Update: A Yoga Program for Patients Undergoing Prostate Cancer Surgery [NA]
A VA-sponsored clinical trial evaluating a yoga program for patients undergoing prostate cancer surgery has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-05-22Clinical Trial Update: Clinical Trial of Low Intensity Shockwaves Therapy for Erectile Dysfunction Post-Radical Prostatectomy [NA]
The clinical trial evaluating low-intensity shockwave therapy for erectile dysfunction after radical prostatectomy has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2022-12-21Clinical Trial Update: Natesto Testosterone Nasal Gel for Hypogonadal Men [Phase 4]
Phase 4 trial of Natesto testosterone nasal gel for hypogonadal men has been withdrawn.
-
EMA withdrawal · 2022-02-28EMA Withdrawn: Vivanza (vardenafil) — Bayer AG
EMA has withdrawn Vivanza (vardenafil) from the market (Bayer AG) for erectile dysfunction.
-
EMA withdrawal · 2021-10-05EMA Application withdrawn: Sildenafil FGK (sildenafil citrate) — FGK Representative Service GmbH
A regulatory application for sildenafil citrate (Sildenafil FGK) has been withdrawn by FGK Representative Service GmbH for erectile dysfunct…
-
CLINICAL_TRIALS withdrawal · 2017-11-24Clinical Trial Update: Autologous Adipose-Derived Stromal Cells Delivered Into the Corpus Cavernous in Patients With Erectile Dysfunction [Phase 1, Phase 2]
A clinical trial using autologous adipose-derived stromal cells delivered into the corpus cavernosum for erectile dysfunction has been withd…
-
CLINICAL_TRIALS withdrawal · 2017-06-20Clinical Trial Update: Low Frequency Shock Wave Therapy for Improving Post-prostatectomy Erectile Dysfunction: a Prospective Pilot Study [NA]
A prospective pilot trial evaluating low frequency shock wave therapy for post-prostatectomy erectile dysfunction was withdrawn from the reg…
-
CLINICAL_TRIALS withdrawal · 2017-01-26Clinical Trial Update: Health Interventions in Men Undergoing Radical Prostatectomy [NA]
This clinical trial update indicates that the Johns Hopkins University study evaluating health interventions for men undergoing radical pros…
-
CLINICAL_TRIALS withdrawal · 2016-04-08Clinical Trial Update: Collagen Scaffolds Loaded With HUCMSCs for the Improvement of Erectile Function in Men With Diabetes [Phase 1]
Phase 1 trial of collagen scaffolds loaded with human umbilical cord mesenchymal stem cells for erectile function in men with diabetes has b…
-
CLINICAL_TRIALS withdrawal · 2016-03-04Clinical Trial Update: Efficacy, Safety and Dose-response of Udenafil in Patients With Benign Prostatic Hyperplasia and Erectile Dysfunction [Phase 2]
Phase 2 trial evaluating udenafil for erectile dysfunction and benign prostatic hyperplasia has been withdrawn. No further development detai…
-
CLINICAL_TRIALS withdrawal · 2015-07-16Clinical Trial Update: Cardiovascular Safety Study of Lodenafil Carbonate in Patients With Coronaropathy During Physical Effort [Phase 4]
Phase 4 cardiovascular safety study of lodenafil carbonate in patients with erectile dysfunction and coronary artery disease has been withdr…
-
CLINICAL_TRIALS withdrawal · 2015-05-25Clinical Trial Update: Stem Cells for the Improvement of Erectile and Cardiac Function in Aging Men [Phase 1]
A Phase 1 stem cell trial investigating erectile dysfunction and cardiovascular function in aging men was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-03-14Clinical Trial Update: Pudendal Assessment in Erectile Dysfunction
The clinical trial evaluating pudendal nerve assessment in erectile dysfunction was terminated.
-
CLINICAL_TRIALS withdrawal · 2014-03-04Clinical Trial Update: Efficacy, Safety and Satisfaction of VITAROS (Transdermal Topical Alprostadil) in Men With Erectile Dysfunction [Phase 4]
The Phase 4 trial evaluating VITAROS (transdermal topical alprostadil) for erectile dysfunction has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2009-02-13Clinical Trial Update: Improvement of Erectile Dysfunction by Fluvastatin in Patients With Cardiovascular Risk Factors [Phase 3]
A Phase 3 clinical trial evaluating erectile dysfunction improvement with fluvastatin in men with cardiovascular risk factors has been withd…
-
EMA withdrawal · 2006-05-29EMA Withdrawn: Uprima (apomorphine hydrochloride) — Abbott Laboratories Ltd.
EMA has withdrawn Uprima (apomorphine hydrochloride) for erectile dysfunction (Abbott Laboratories Ltd.).